Viatris (VTRS) News Today $8.95 -0.35 (-3.76%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$8.97 +0.02 (+0.22%) As of 03/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens BermanMarch 25 at 3:01 PM | globenewswire.comIs Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?March 25 at 2:45 PM | insidermonkey.comViatris Inc. stock rises Monday, still underperforms marketMarch 24 at 9:05 PM | marketwatch.comVTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRSMarch 24 at 2:41 PM | prnewswire.comViatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. ...March 23 at 10:26 AM | gurufocus.comViatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsMarch 23 at 9:25 AM | globenewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMarch 23 at 8:33 AM | globenewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - VTRSMarch 21, 2025 | markets.businessinsider.comViatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens BermanMarch 21, 2025 | globenewswire.comViatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. ...March 20, 2025 | gurufocus.comViatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsMarch 20, 2025 | globenewswire.comViatris Q4 Earnings TranscriptMarch 20, 2025 | marketbeat.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMarch 19, 2025 | globenewswire.comVTRS Investigation: Rosen Law Firm Encourages Viatris Inc. ...March 18, 2025 | gurufocus.comVTRS Investigation: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRSMarch 18, 2025 | prnewswire.comIs Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?March 17, 2025 | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRSMarch 17, 2025 | prnewswire.comViatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens BermanMarch 17, 2025 | globenewswire.comViatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. ...March 16, 2025 | gurufocus.comViatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsMarch 16, 2025 | globenewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMarch 15, 2025 | globenewswire.comViatris Inc. stock rises Friday, still underperforms marketMarch 15, 2025 | marketwatch.comRosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRSMarch 15, 2025 | tmcnet.comRosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation – VTRSMarch 14, 2025 | businesswire.comRosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action ...March 14, 2025 | gurufocus.comSecurities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMarch 13, 2025 | morningstar.comViatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA ...March 13, 2025 | gurufocus.comViatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens BermanMarch 13, 2025 | globenewswire.comSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMarch 13, 2025 | prnewswire.comViatris Inc. (VTRS) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMarch 13, 2025 | tmcnet.comSecurities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law FirmMarch 12, 2025 | businesswire.comViatris Inc. (VTRS) Barclays 27th Annual Global Healthcare Conference (Transcript)March 11, 2025 | seekingalpha.comSecurities Fraud Investigation Into Viatris Inc. (VTRS) Announced - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMarch 11, 2025 | tmcnet.comBronstein, Gewirtz & Grossman, LLC Encourages Viatris Inc. (VTRS) Shareholders to Inquire about Securities InvestigationMarch 11, 2025 | markets.businessinsider.comSecurities Fraud Investigation Into Viatris Inc. (VTRS) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMarch 11, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRSMarch 11, 2025 | prnewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMarch 9, 2025 | globenewswire.comEx-Dividend Reminder: Evergy, Viatris and Becton, DickinsonMarch 8, 2025 | nasdaq.comForecasting The Future: 4 Analyst Projections For ViatrisMarch 7, 2025 | nasdaq.comViatris to Present at the Barclays 27th Annual Global Healthcare ConferenceMarch 5, 2025 | prnewswire.comINVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisMarch 5, 2025 | globenewswire.comWall Street Wary as Viatris (VTRS) Dives into Generic Weight Loss Drug MarketMarch 4, 2025 | tipranks.comLevi & Korsinsky Investigates Possible Securities Fraud Violations by Viatris Inc. (VTRS)March 4, 2025 | markets.businessinsider.comViatris: A Unique S&P 500 'Fallen Angel' With Intriguing PotentialMarch 4, 2025 | seekingalpha.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc. - VTRSMarch 3, 2025 | prnewswire.comIs Viatris Inc. (VTRS) the Best Weight Loss Drug Stock to Buy According to Analysts?March 1, 2025 | insidermonkey.comViatris plummets sharply on disappointing fourth-quarter, 2025 outlookMarch 1, 2025 | za.investing.comStock Of The Day: Why The Viatris Meltdown Ended Where It DidFebruary 28, 2025 | benzinga.comViatris slides as FDA scrutiny on India plant clouds outlookFebruary 28, 2025 | msn.comViatris Inc (VTRS) Q4 2024 Earnings Call Highlights: Strong Cash Flow and Debt Reduction Amid ...February 28, 2025 | finance.yahoo.com Remove Ads Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address VTRS Media Mentions By Week VTRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTRS News Sentiment▼-0.030.74▲Average Medical News Sentiment VTRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTRS Articles This Week▼144▲VTRS Articles Average Week Remove Ads Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Intra-Cellular Therapies News Moderna News Genmab A/S News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTRS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viatris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viatris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.